Tariffied, oil PSUs stop buying Russian crude in spot market

1754239514 articleshow


State-run refiners-Indian Oil Corporation, Bharat Petroleum Corporation, Hindustan Petroleum Corporation, and Mangalore Refineries and Petrochemicals Ltd (MRPL)-have stopped procuring Russian crude oil from the spot market in the wake of tariffs levied by the US, according to two sources aware of the development.

US President Donald Trump on Wednesday imposed a 25% tariff on Indian exports effective August 1, 2025. He coupled these tariffs with an “additional penalty” for India’s strategic trade relationship with Moscow, especially its oil purchases and military imports.

India is the world’s third-largest oil-importing and consuming nation, and IOCL, BPCL, HPCL, and MRPL procure nearly 40% of their crude oil requirement from the spot market. These refineries control 60% of India’s refining capacity.

Screenshot 2025-08-01 at 12.17.08 AM

“Refiners will shift to procuring crude from Middle East as well as other countries as was the case earlier. Though this will be more expensive than Russian Urals and will impact the gross refining margins,” said one of the sources mentioned above.

However, Reliance Industries and Nayara Energy, which procure crude on a term basis from Russia, may continue to buy, sources said. The two, over the past years, have profited from exporting refined products to Europe, their most profitable market.


IOCL, BPCL, HPCL, MRPL, RIL, and Nayara Energy did not respond to an email query till press time.On July 17, oil minister Hardeep Singh Puri warned that taking Russian supplies off the market could push oil prices to $130-140 per barrel, detailing the potential impact of secondary sanctions. India would quickly switch to alternative sources to meet its oil demand if any supply were cut off, Puri said, adding that the world is currently awash in oil, which is helping keep prices in check.India’s crude oil imports from Russia were around $50.3 billion in FY25, more than one-third of India’s total crude expenditure of $143.1 billion.



Source link

Disclaimer


We strive to uphold the highest ethical standards in all of our reporting and coverage. We 5guruayurveda.com want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on. For any glitch kindly connect at 5guruayurveda.com

Leave a Reply

Your email address will not be published. Required fields are marked *